NOVO NORDISK , SANOFI - Tresiba and Ryzodeg Delayed in the US: Lantus Protected - Reduce PT to DKK 950 - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-14 08:57:01
Post complete response letter issued by the USFDA to NOVOB for Tresiba and Ryzodeg, we reduce our PT for NOVOB from DKK 1000 to DKK 950. Considering the US constitutes the biggest long acting insulin market (Lantus-US sales: $4b; Western EU: $1.0b; RoW: $400m; Emerg mkt: $1.0b), the CRL has clouded the optimism over revenue potential of this important pipeline asset.
We had forecasted a slow ramp up and peak sales of $1.5b (incremental sales for Tresiba / Ryzodeg excluding cannibalization of Levemir), which we now reduce to $500million. Although the delay does not have any impact on near term earnings, but has long term implications for market share in a competitive next generation insulin market. We expect a 3-4 years delay would put NOVOB behind SAN and LLY in the launch of next generation insulin.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.